Cargando…
Multiplex quantification of C-terminal alpha-1-antitrypsin peptides provides a novel approach for characterizing systemic inflammation
C-terminal peptides (CAAPs) of the highly abundant serine protease alpha-1-antitrypsin (A1AT) have been identified at various lengths in several human materials and have been proposed to serve as putative biomarkers for a variety of diseases. CAAPs are enzymatically formed and these enzymatic activi...
Autores principales: | Bigalke, Arite, Sponholz, Christoph, Schnabel, Claudia, Bauer, Michael, Kiehntopf, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8907207/ https://www.ncbi.nlm.nih.gov/pubmed/35264629 http://dx.doi.org/10.1038/s41598-022-07752-w |
Ejemplares similares
-
C-Terminal Alpha-1 Antitrypsin Peptide: A New Sepsis Biomarker with Immunomodulatory Function
por: Blaurock, Nancy, et al.
Publicado: (2016) -
Algicidal bacteria trigger contrasting responses in model diatom communities of different composition
por: Bigalke, Arite, et al.
Publicado: (2019) -
A Novel Mouse Monoclonal Antibody C42 against C-Terminal Peptide of Alpha-1-Antitrypsin
por: Tumpara, Srinu, et al.
Publicado: (2021) -
Safety and efficacy of alpha-1-antitrypsin augmentation therapy in the treatment of patients with alpha-1-antitrypsin deficiency
por: Petrache, Irina, et al.
Publicado: (2009) -
Mineralization of alpha-1-antitrypsin inclusion bodies in Mmalton alpha-1-antitrypsin deficiency
por: Callea, Francesco, et al.
Publicado: (2018)